About King Laboratories
King Laboratories is a Healthcare company. Pharmaceutical manufacturing and research are conducted by King Laboratories in healthcare sectors, focusing on generics, oncology, and respiratory therapies across global markets. Its Indian entity King Laboratories Private Limited reported revenue of ₹52.8 Lakh. King Laboratories offers products and services including Generic Drugs and Oncology Therapies. Its focus areas include Manufacturing, Generic Drugs, Formulations and Parenteral and Pharmaceuticals.
Company details
King Laboratories is recognized as a research-based pharmaceutical entity that operates with offices in over 50 countries and manufacturing facilities in four nations, where advanced therapies for dermatology, oncology, and respiratory conditions are developed to improve patient quality of life globally. Investments in research and development, including 6-7 of turnover and over 1,00,000 sq ft of dedicated space, are utilized by a team of 550 scientists to create generics, biosimilars, and parenteral products. Accreditations from international regulatory bodies are held by the company, ensuring compliance and a competitive edge in the generic market, while environmental health and safety standards are maintained through ongoing resource allocation. This structure supports a vertically-integrated approach across the pharmaceutical value chain, fostering innovation in differentiated medicines.
- SectorsHealthcare
- Email••••••••
- Social Facebook
- Legal Name King Laboratories Private Limited
- Date of Incorporation 30 May, 2013
- Jurisdiction Srinagar, Jammu and Kashmir, India
- Indian entity revenue₹52.8 Lakh
FY 2025 · +296% YoY
- Indian entity net profit₹92,119
FY 2025 · 2% margin
- Indian entity EBITDA₹4.1 Lakh
FY 2025 · 8% margin
Associated legal entities of King Laboratories
King Laboratories operates through King Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| King Laboratories Private Limited CIN U24100JK2013PTC003895 | Active | 30 May 2013 | Srinagar, Jammu and Kashmir | ₹0.5 Cr | 2 | View details |
Products & Services of King Laboratories
King Laboratories offers a comprehensive portfolio of products and services, including Generic Drugs and Oncology Therapies.
Generic drugs are manufactured by King Laboratories for major therapeutic segments, covering dosage forms like oral solids and powders, with a focus on vertical integration and global distribution.
Oncology therapies are developed by King Laboratories as advanced treatments for enriching patient lives, including biosimilars and formulations that are supported by research centers worldwide.
Board of directors of King Laboratories Private Limited (King Laboratories)
King Laboratories Private Limited is the primary company behind King Laboratories. The board of King Laboratories Private Limited currently have 2 directors; the longest-serving is Bhat Rouf Ahmad, appointed in 2013.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bhat Rouf Ahmad DIN 06589185 | Director | 30 May 2013 | 13 yrs 5 mo | King Laboratories Private Limited |
| Taslim Arif Dar DIN 06589175 | Managing Director | 30 May 2013 | 13 yrs 5 mo | King Laboratories Private Limited |
Financials of King Laboratories
Figures of King Laboratories Private Limited, the primary company behind King Laboratories, for FY 2025. Revenue was ₹52.8 Lakh (+296% year on year). Net profit was ₹92,119 (2% margin). EBITDA was ₹4.1 Lakh (8% margin). Revenue has grown at a compounded annual rate of -9% over three years and +2% over five years.
- ₹52.8 LakhRevenue · FY 2025 · +296% YoY
- ₹92,119Net profit · 2% margin
- ₹4.1 LakhEBITDA · 8% margin
- ₹7 LakhPaid-up capital
- -9%Revenue CAGR, 3 years
- +2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of King Laboratories Private Limited are on its company page.
Detailed financial statements for King Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about King Laboratories
The primary company behind King Laboratories, King Laboratories Private Limited, reported revenue of ₹52.8 Lakh for FY 2025, up 296% year on year.
King Laboratories is recognized as a research-based pharmaceutical entity that operates with offices in over 50 countries and manufacturing facilities in four nations, where advanced therapies for dermatology, oncology, and respiratory conditions are developed to improve patient quality of life globally. Investments in research and development, including 6-7 of turnover and over 1,00,000 sq ft of dedicated space, are utilized by a team of 550 scientists to create generics, biosimilars, and parenteral products. Accreditations from international regulatory bodies are held by the company, ensuring compliance and a competitive edge in the generic market, while environmental health and safety standards are maintained through ongoing resource allocation. This structure supports a vertically-integrated approach across the pharmaceutical value chain, fostering innovation in differentiated medicines.
King Laboratories offers Generic Drugs and Oncology Therapies.
King Laboratories operates through King Laboratories Private Limited.
The legal entities of King Laboratories currently have 2 directors, including Bhat Rouf Ahmad, Taslim Arif Dar.